Deeks SG - Search Results

1

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.

Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Sette A, Weiskopf D, Kumar N, Lynch KL, Hunt PW, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Glidden DV, Gandhi M, Deeks SG, Rutishauser RL, Henrich TJ. Peluso MJ, et al. Among authors: deeks sg. AIDS. 2022 Oct 1;36(12):F7-F16. doi: 10.1097/QAD.0000000000003338. Epub 2022 Jul 18. AIDS. 2022. PMID: 35866847 Free PMC article.

2

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Hellerstein M, et al. Nat Med. 1999 Jan;5(1):83-9. doi: 10.1038/4772. Nat Med. 1999. PMID: 9883844

3

Factors influencing T-cell turnover in HIV-1-seropositive patients.

McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. McCune JM, et al. J Clin Invest. 2000 Mar;105(5):R1-8. doi: 10.1172/JCI8647. J Clin Invest. 2000. PMID: 10712441 Free PMC article.

4

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

5

Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients.

Parkin NT, Deeks SG, Wrin MT, Yap J, Grant RM, Lee KH, Heeren D, Hellmanna NS, Petropoulos CJ. Parkin NT, et al. Among authors: deeks sg. AIDS. 2000 Dec 22;14(18):2877-87. doi: 10.1097/00002030-200012220-00009. AIDS. 2000. PMID: 11153669 Clinical Trial.

6

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Deeks SG, et al. N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Free article. Clinical Trial.

7

Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient.

Deeks SG, Martin JN. Deeks SG, et al. AIDS. 2001 Jan 5;15(1):117-9. doi: 10.1097/00002030-200101050-00017. AIDS. 2001. PMID: 11192853 No abstract available.

8

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.

Liegler TJ, Hayden MS, Lee KH, Hoh R, Deeks SG, Granta RM. Liegler TJ, et al. Among authors: deeks sg. AIDS. 2001 Jan 26;15(2):179-84. doi: 10.1097/00002030-200101260-00006. AIDS. 2001. PMID: 11216925

9

Cerebrospinal fluid response to structured treatment interruption after virological failure.

Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Price RW, et al. Among authors: deeks sg. AIDS. 2001 Jul 6;15(10):1251-9. doi: 10.1097/00002030-200107060-00006. AIDS. 2001. PMID: 11426069

10

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN. Deeks SG, et al. AIDS. 2002 Jan 25;16(2):201-7. doi: 10.1097/00002030-200201250-00009. AIDS. 2002. PMID: 11807304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

676 results

Search Page